Literature DB >> 8726151

Bronchoalveolar lavage or oropharyngeal cultures to identify lower respiratory pathogens in infants with cystic fibrosis.

D S Armstrong1, K Grimwood, J B Carlin, R Carzino, A Olinsky, P D Phelan.   

Abstract

As collections of lower respiratory tract specimens from young children with cystic fibrosis (CF) are difficult, we determined whether oropharyngeal cultures predicted lower airway pathogens. During 1992-1994, 75 of 90 (83%) infants with CF diagnosed by neonatal screening had 150 simultaneous bronchoalveolar lavage (BAL) and oropharyngeal specimens collected for quantitative bacterial culture at a mean age of 17 months (range, 1-52). Ten children undergoing bronchoscopy for stridor served as controls. Total and differential cell counts and interleukin-8 concentrations were measured in BAL fluid. A subset of bacterial pathogens were typed by pulsed field gel electrophoresis. A non-linear relationship with inflammatory markers supported a diagnosis of lower airway infection when > or = 10(5) colony-forming units/ml were detected. This criterion was met in 47 (31%) BAL cultures from 37 (49%) children. Staphylococcus aureus (19%), Pseudomonas aeruginosa (11%), and Hemophilus influenzae (8%) were the major lower airway pathogens. In oropharyngeal cultures, S. aureus (47%), Escherichia coli (23%), H. influenzae (15%), and P. aeruginosa (13%) predominated. The sensitivity, specificity, and positive and negative predictive values of oropharyngeal cultures for pathogens causing lower respiratory infections were 82%, 83%, 41%, and 97%, respectively. When there was agreement between paired oropharyngeal and BAL cultures, genetic fingerprinting showed some strains of the same organism were unrelated. We conclude that oropharyngeal cultures do not reliably predict the presence of bacterial pathogens in the lower airways of young CF children.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8726151     DOI: 10.1002/(SICI)1099-0496(199605)21:5<267::AID-PPUL1>3.0.CO;2-K

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  72 in total

1.  Pulmonary oxidative stress response in young children with cystic fibrosis.

Authors:  J Hull; P Vervaart; K Grimwood; P Phelan
Journal:  Thorax       Date:  1997-06       Impact factor: 9.139

2.  Cough plate versus cough swab in patients with cystic fibrosis; a pilot study.

Authors:  S Maiya; M Desai; A Baruah; P Weller; J R Clarke; J Gray
Journal:  Arch Dis Child       Date:  2004-06       Impact factor: 3.791

Review 3.  Inhaled antibiotics in cystic fibrosis: what's new?

Authors:  Simon Langton Hewer
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

Review 4.  Cystic fibrosis modifier genes.

Authors:  Jane Davies; Eric Alton; Uta Griesenbach
Journal:  J R Soc Med       Date:  2005       Impact factor: 5.344

5.  Clinical outcome in relation to care in centres specialising in cystic fibrosis. Cross infection with Pseudomonas aeruginosa is unusual.

Authors:  D Spencer
Journal:  BMJ       Date:  1999-01-02

6.  Human beta-defensin 2 is a salt-sensitive peptide antibiotic expressed in human lung.

Authors:  R Bals; X Wang; Z Wu; T Freeman; V Bafna; M Zasloff; J M Wilson
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

7.  Early airway infection, inflammation, and lung function in cystic fibrosis.

Authors:  G M Nixon; D S Armstrong; R Carzino; J B Carlin; A Olinsky; C F Robertson; K Grimwood; Claire Wainwright
Journal:  Arch Dis Child       Date:  2002-10       Impact factor: 3.791

8.  Mucosal and systemic antibody responses to potential Pseudomonas aeruginosa vaccine protein antigens in young children with cystic fibrosis following colonization and infection.

Authors:  Ryka Moore; Jennelle M Kyd; Rosemary Carzino; Davide Armstrong; Keith Grimwood; Diana C Otczyk; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2012-12-18       Impact factor: 3.452

Review 9.  Newborn screening for cystic fibrosis.

Authors:  Jack K Sharp; Michael J Rock
Journal:  Clin Rev Allergy Immunol       Date:  2008-12       Impact factor: 8.667

10.  Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

Authors:  Scott D Sagel; Ronald L Gibson; Julia Emerson; Sharon McNamara; Jane L Burns; Jeffrey S Wagener; Bonnie W Ramsey
Journal:  J Pediatr       Date:  2008-09-25       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.